CAS No. |
52187-80-1 |
中文名称 |
5-羟基-2-[4-羟基-3-[((2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基]苯基]-7-[((2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基]-4H-色烯-4-酮 |
英文名称 |
5-Hydroxy-2-(4-hydroxy-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)phenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one |
别名 |
7-(beta-D-glucopyranosyloxy)-2-[3-(beta-D-glucopyranosyloxy)-4-hydroxyphenyl]-5-hydroxy-4H-1-benzopyran-4-one;LUTEOLIN-3',7-DIGLUCOSIDE;LUTEOLIN-3',7-DI-O-GLUCOSIDE;LUTEOLIN-7,3'-DIGLUCOSIDE;LUTEOLIN-7,3'-DI-O-GLUCOSIDE;LUTEOLIN-7,3''-DI-O-GLUCOSIDE WITH HPLC;2-(3-β-D-Glucopyranosyloxy-4-hydroxyphenyl)-7-(β-D-glucopyranosyloxy)-5-hydroxy-4H-1-benzopyran-4-one;7-(β-D-Glucopyranosyloxy)-2-[3-(β-D-glucopyranosyloxy)-4-hydroxyphenyl]-5-hydroxy-4H-1-benzopyran-4-one |
标准英文名 |
5-hydroxy-2-(4-hydroxy-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)phenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one |
MDL No. |
MFCD00017467 |
分子式 |
C27H30O16 |
分子量 |
610.52
|
精确分子量 |
610.15
|
SMILES |
O=C1C2=C(O)C=C(O[C@@H]3O[C@@H]([C@H]([C@@H]([C@H]3O)O)O)CO)C=C2OC(C4=CC(O[C@@H]5O[C@@H]([C@H]([C@@H]([C@H]5O)O)O)CO)=C(C=C4)O)=C1 |
标准SMILES |
OC1C=C(C=C2OC(=CC(=O)C=12)C1=CC(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)=C(O)C=C1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O |
用途 |
Luteolin-3′,7-diglucoside significantly inhibits cataract formation induced in sheep lenses; it also inhibits the activity of both ATCC and clinical strains of Ureaplasma urealyticum. |
InChIKey |
BISZYPSIZGKOFA-IPOZFMEPSA-N |